clinical trial · NCT06785571
The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Multicenter, Randomized, Single-blinded, Parallel, Two-step Trial
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology·phase3·recruiting·n = 204
Respiratory InsufficiencyNalbuphine hydrochloride injectionHydromorphone hydrochloride injection
brief summary
The analgesic effect of nalbuphine hydrochloride injection will be evaluated in a multicenter, randomized, single-blind, parallel, positive-controlled approach in two steps: step 1, to explore the optimal dosage of nalbuphine hydrochloride injection with 2 experimental arms and 1 positive control and step 2, to evaluate the effectiveness and safety of nalbuphine hydrochloride injection in mechanically ventilated ICU patients at a dosage determined in step 1 with the same positive control.
started
Aug 30, 2023
primary completion
Oct 31, 2025
completion
Oct 31, 2025
last updated
Jan 21, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol